US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Dr Ing H C F Porsche AG (PK) (DRPRF) 銘柄情報

Dr Ing H C F Porsche AG (PK) (DRPRF)

55.55

0.00

(0.00%)

終了 6月7日 5:00AM

Dr Ing H C F Porsche AG (PK) (DRPRF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

55.55

( - )

買値

53.17

売値

56.41

出来高

25

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

55.55

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 621,869

発行済株式数

911,000,000

配当利回り

1.01 (2.20%)

PER

-

1 株当たり利益 (EPS)

-

歳入

35.81B

純利益

313M

Dr. Ing. h.c. F. Porsche AG engages in automotive and financial services business in Germany, Europe, North America, China, and internationally. The company procures, develops, manufactures, and sells vehicles, as well as related services. It also offers leasing, dealer and customer financing, mobil... Dr. Ing. h.c. F. Porsche AG engages in automotive and financial services business in Germany, Europe, North America, China, and internationally. The company procures, develops, manufactures, and sells vehicles, as well as related services. It also offers leasing, dealer and customer financing, mobility services for Porsche brand vehicles, and other finance-related services. The company was formerly known as Porsche Fünfte Vermögensverwaltung AG and changed its name to Dr. Ing. h.c. F. Porsche AG in November 2009. The company was founded in 2009 and is headquartered in Stuttgart, Germany. Dr. Ing. h.c. F. Porsche AG is a subsidiary of Porsche Holding Stuttgart GmbH. 詳細を表示

セクター

Consumer Discretionary

業界

Vehicles

ウェブサイト

www.porsche.com

本社

Stuttgart, Germany

設立

2026

Dr Ing H C F Porsche AG (PK) is listed in the Consumer Discretionary sector of the その他OTC with ticker DRPRF. The last closing price for Dr Ing H C F Porsche (PK) was US$55.55. Over the last year, Dr Ing H C F Porsche (PK) shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Dr Ing H C F Porsche (PK) currently has 911,000,000 shares in issue. The market capitalisation of Dr Ing H C F Porsche (PK) is US$50.61 billion.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	PR
4	0	0	0	0	0	0	0	PR
12	0	0	0	0	0	0	0	PR
26	0	0	0	0	0	0	0	PR
52	0	0	0	0	0	0	0	PR
156	0	0	0	0	0	0	0	PR
260	0	0	0	0	0	0	0	PR

DRPRF - Frequently Asked Questions (FAQ)

What is the current Dr Ing H C F Porsche AG (PK) share price?

The current share price of Dr Ing H C F Porsche AG (PK) is US$ 55.55

How many Dr Ing H C F Porsche AG (PK) shares are in issue?

Dr Ing H C F Porsche AG (PK) has 911,000,000 shares in issue

What is the market cap of Dr Ing H C F Porsche AG (PK)?

The market capitalisation of Dr Ing H C F Porsche AG (PK) is USD 50.61B

What is the 1 year trading range for Dr Ing H C F Porsche AG (PK) share price?

Dr Ing H C F Porsche AG (PK) has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the cash to sales ratio of Dr Ing H C F Porsche AG (PK)?

The cash to sales ratio of Dr Ing H C F Porsche AG (PK) is 1.21

What is the registered address of Dr Ing H C F Porsche AG (PK)?

The registered address for Dr Ing H C F Porsche AG (PK) is Porscheplatz 1, Stuttgart, Baden-Württemberg, 70435

What is the Dr Ing H C F Porsche AG (PK) website address?

The website address for Dr Ing H C F Porsche AG (PK) is www.porsche.com/international

Which industry sector does Dr Ing H C F Porsche AG (PK) operate in?

Dr Ing H C F Porsche AG (PK) operates in the Vehicles sector

capgain

capgain 6分前

Charlie Starr - Full Performance (30A Songwriters Sessions)

https://www.youtube.com/watch?v=agjjBk1N2n0

Lacey1

Then what is it Bio? If not to endorce a new line of research that addresses the advancement of treatment from the experts in the field who treat patients daily.

train21

train21 8分前

$SNTX
Leal not trust worthy and nothing verified
bringing more persons in to share the blame is all
share price is steady around a penny for weeks like it was controlled ?
I am out again will go back in at the bottom
good luck to all

juicyjuice10002

juicyjuice10002 9分前

https://www.nytimes.com/2026/06/04/us/politics/supreme-court-sec-disgorgement.html

This Supreme Court ruling is a major victory for the SEC (Securities and Exchange Commission). Essentially, it means the SEC can still force fraudsters to give back their illegal profits, even if they c

spdpro

spdpro 12分前

Emini Barry >
https://youtu.be/bqGR4904Ymo

eastunder

eastunder 13分前

QNT

6-4-26

60.00

6-4-2026 IPO 60.00

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177116335 Quantinuun, Inc. (Nyse: QNT)

https://www.sec.gov/edgar/search/#/ciks=0002110105&entityName=Quantinuum%2520Inc.%2

learningcurve2020

learningcurve2020 14分前

Very predictable you’d all ignore this GBM patient / Hedge fund manager article. I’m sure the disciples are all huddling over on DanishDud’s shiny new site. LOL. Can’t make it up.

https://www.cnbc.com/2026/06/05/warren-buffett-disciple-guy-spiers-rare-cancer-made-him-revalu

Green Leaf Smoker

Green Leaf Smoker 15分前

Well I'll be damn"ed" MJNA goes down! Here's the BEAR link to POS MJNA ....Enough Said
https://investorshub.advfn.com/stock-market/USOTC/medical-marijuana-id-MJNA/trades#google_vignette
.....current Bail Out SP O.OOO1 No Kid wants ones 50% + stock loss 🤣😂🤣

B RY

"Jensen Huang just gave one of the most bullish signals yet for the memory industry $MU $DRAM

$NVDA released 4 new products and at NVIDIA’s Korea event, he repeatedly emphasized one thing: more memory.

• Vera Rubin supercomputers need massive amounts of HBM
• Ve

IhidfromtheX

IhidfromtheX 17分前

Until there's a paradigm shift in the OG's thinking, precision medicine is stalled. The company now is back to its beginnings. Missling failed in proving to the OG that his methodology of small studies is the correct way to judge approving medications. The Anavex drug may or may not be the eye ca

train21

train21 17分前

$GTVH ...........also Texas state security's board ................512-305-8300
Texas has no corporate income tax so they got away with that so cant trace if they really made any money at all ?
legacystock transfer.com is also in Addison Texas CEO Denise Bogutski

shadolane

shadolane 19分前

After your comments the question is what larger organization wants Amarin? Further, on what basis would they be interested? Repurposing and oncology are still to be defined. This could take significant time to evolve.

As you suggested, civil comments are welcomed.

cottonmather

cottonmather 21分前

Steve Poplar. The world goes boom. 20 minutes https://youtu.be/ToCChF4J-e0?si=oWE-Aaq6QaExeoSb

learningcurve2020

learningcurve2020 23分前

Charlie gets it.

https://nypost.com/2026/06/06/opinion/andrew-left-faces-20-years-in-prison-but-having-a-correct-opinion-about-a-stock-shouldnt-be-a-crime/

mascale

mascale 23分前

Qatar owners/shareholders easily post transparency.

mascale

mascale 24分前

Qatar validated public record v. IHUB post(s): Noted!

learningcurve2020

learningcurve2020 24分前

About ten years ago I remember Flip said he had a letter in his back pocket waiting to go to the SEC. Could’ve been Happy but almost certainly it was Flip.

BIOChecker4

BIOChecker4 26分前

Why does this myth that scientists who put their names on a peer-reviewed paper are endorsing anything? It is demonstrably false and shows a lack of understanding about what the peer review process is.

Nelson2

Nelson2 27分前

Lol! I feel the exact same way about him BRUTAL!
GLTU

The Truth Hurts

The Truth Hurts 28分前

Name was updated to Metaterra Holdings.
Not the symbol yet.

oldman69

oldman69 30分前

25 bucks and beyond 🤣😅

oldman69

oldman69 30分前

25 bucks and beyond 🤣😅

train21

train21 33分前

they block me and all the insiders also blocked me, the ones that received the private email right before the $gtvh 0036 giant drop down ?
if a CEO blocks people from asking questions that's a big bad sign post right there
its a 2 company share selling scam run by

prowler3701

prowler3701 37分前

"high-profile advisors". The buffoon CEO definitely could use some of these as 17 years of failure is adding up ;^)

Jack Wagon CEO!!

Dr Ing H C F Porsche (PK)

CIBC International Equit...

Bond 5.852% until 23.02....

Alger Concentrated Equit...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。